Biotechnology - UK, Research

Filter

Current filters:

UKResearch

Popular Filters

Syncona and UCL Business form cancer immunotherapy company Autolus

Syncona and UCL Business form cancer immunotherapy company Autolus

22-01-2015

Investment company Syncona and UCL Business, the wholly-owned technology transfer company of University…

BiologyBiotechnologyOncologyResearchUK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

16-12-2014

A new biomedical laboratory, the Biomedical Innovation Hub (the BioHub) has opened in Birmingham, UK.

BiotechnologyBirminghamResearchUKUnited Kingdom

Medical Research Council develops XNAzyme, a world-first synthetic enzyme

Medical Research Council develops XNAzyme, a world-first synthetic enzyme

01-12-2014

Scientists from the UK's Medical Research Council have created the world’s first artificial enzymes…

BiotechnologyChemistryGeneticsMedical Research CouncilResearchUK

AstraZeneca, Pharmacyclics and Janssen team up on Imbruvica and MEDI4736 combination trial

AstraZeneca, Pharmacyclics and Janssen team up on Imbruvica and MEDI4736 combination trial

04-11-2014

Anglo-Swedish drug major AstraZeneca and US health care giant Johnson & Johnson’s Europe-based subsidiary…

AstraZenecaBiotechnologyImbruvicaJanssenMEDI4736OncologyPharmacyclicsResearchUK

Auspherix and Domainex collaborate for new drugs to combat antibiotic-resistance

Auspherix and Domainex collaborate for new drugs to combat antibiotic-resistance

15-10-2014

UK biotech firm Domainex and Australian drug discovery company Auspherix, a spin-out from the University…

AuspherixAuspherix PtyAustraliaBiotechnologyDomainexHealthLicensingPharmaceutical sciencesPharmacologyResearchUK

Smith & Nephew shares fall as HP802-247 living cell spray-on therapy fails to meet primary endpoint

Smith & Nephew shares fall as HP802-247 living cell spray-on therapy fails to meet primary endpoint

14-10-2014

Global medical technology business Smith & Nephew has found its Phase III study of HP802-247, a living…

Antibiotics and Infectious diseasesBiotechnologyHP802-247ResearchSmith & NephewUK

UK Bioscience Forum: Incentivize investors to hold their investment for more than 10 years

UK Bioscience Forum: Incentivize investors to hold their investment for more than 10 years

08-10-2014

One of the main messages from the keynote speech at the UK Bioscience Forum by Paul Drayson, chief executive…

BiotechnologyLegalLicensingPatents & Trade marksProductionRegulationResearchSocial IssuesUK

Yale's Stephen Waxman to collaborate with Convergence Pharmaceuticals on chronic pain

Yale's Stephen Waxman to collaborate with Convergence Pharmaceuticals on chronic pain

06-10-2014

Convergence Pharmaceuticals Holdings, focused on developing analgesic medicines, is to collaborate with…

AnalgesiaBiotechnologyConvergence PharmaceuticalsResearchUK

Oxford BioTherapeutics and Berlin Chemie/Menarini update on $1 billion oncology investment alliance

Oxford BioTherapeutics and Berlin Chemie/Menarini update on $1 billion oncology investment alliance

02-10-2014

UK biotech firm Oxford BioTherapeutics and family-owned Italian Berlin Chemie/Menarini Group have designated…

BiotechnologyItalyMenariniOncologyOxford BioTherapeuticsResearchUK

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

Avacta Life Sciences invests $16.2 million in Affimers as engineered alternative to antibodies

30-09-2014

Avacta Life Sciences, a division of Avacta Group is investing £10 million ($16.2 million) in the launch…

AvactaBiotechnologyResearchUK

AstraZeneca's Medimmune to collaborate on new oncology biologics lab with Cancer Research UK

AstraZeneca's Medimmune to collaborate on new oncology biologics lab with Cancer Research UK

25-09-2014

Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca,…

BiotechnologyCancer Research TechnologyCancer Research UKMedImmuneOncologyResearchUK

UK cancer charity partners with Asterias Biotherapies on lung cancer vaccine

UK cancer charity partners with Asterias Biotherapies on lung cancer vaccine

15-09-2014

The charity Cancer Research UK and its commercialization arm Cancer Research Technology (CRT), have reached…

Asterias BiotherapeuticsBiotechnologyBioTimeCancer Research TechnologyLicensingOncologyResearchUKVaccines

XenoPort to collaborate with the NIAAA for Horizant trial

XenoPort to collaborate with the NIAAA for Horizant trial

10-09-2014

Neurological biopharma specialist XenoPort is to enter into an agreement with the National Institute…

Alcohol abuseBiotechnologyHorizantNational Institute on Alcohol Abuse and AlcoholismNeurologicalResearchUKXenoPort

ERS 2014: Encouraging new data with AstraZeneca’s benralizumab

ERS 2014: Encouraging new data with AstraZeneca’s benralizumab

08-09-2014

Anglo-Swedish drug major AstraZeneca today announced that The Lancet Respiratory Medicine has published…

AstraZenecabenralizumabBiotechnologyCOPDGermanyHealth Medical PharmaPulmonologyResearchRespiratory and PulmonaryRespiratory therapyUK

UK aims to become world number one in DNA testing with new investment

UK aims to become world number one in DNA testing with new investment

01-08-2014

David Cameron, the UK Prime Minister, has announced a package of investment worth more than £300 million…

BiotechnologyDavid CameronGeneticsIlluminaMedical Research CouncilResearchUK

Life Sciences Hub launched in Wales to support industry

Life Sciences Hub launched in Wales to support industry

17-07-2014

The Welsh Government has today launched the Life Sciences Hub Wales, a national and international focal…

BiotechnologyResearchUKWales

UK budget unveils £55 million Cell Therapy Manufacturing Centre

UK budget unveils £55 million Cell Therapy Manufacturing Centre

19-03-2014

The UK’s annual budget speech by Chancellor of the Exchequer George Osborne today included the announcement…

BiotechnologyFinancialPoliticsResearchUK

Argenta and Antabio meet milestone in anti-bacterial drug discovery collaboration

Argenta and Antabio meet milestone in anti-bacterial drug discovery collaboration

10-03-2014

Drug discovery company Argenta, a subsidiary of Belgian drugmaker Galapagos (Euronext: GLPG), has achieved…

Antibiotics and Infectious diseasesArgentaBiotechnologyFranceResearchUK

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

04-02-2014

A UK-based mobile human monitoring company is making waves in health care as it aims to revolutionize…

BiotechnologyInterviewsPharmaceuticalResearchUK

Heptares meets milestone in MedImmune research collaboration

Heptares meets milestone in MedImmune research collaboration

23-01-2014

UK-based drug company Heptares Therapeutics has successfully completed the research phase of its antibody…

AstraZenecaBiotechnologyHeptares TherapeuticsMedImmuneResearchUK

Nuevolution signs international deal to screen potential cancer drugs using DNA tags

Nuevolution signs international deal to screen potential cancer drugs using DNA tags

22-01-2014

An innovative screening technology that tags compounds with unique strands of DNA will be used to assess…

BiotechnologyDenmarkNuevolutionOncologyResearchUK

Molecular nano-spies created to aid disease detection

Molecular nano-spies created to aid disease detection

14-01-2014

Stealth nano compounds have been designed by researchers at the UK’s University of Nottingham’s School…

BiotechnologyResearchUK

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

16-12-2013

The UK’s brightest bioscience companies met in London for the One Nucleus Genesis 2013 conference on…

BiotechnologyFinancialInterviewsMerck SeronoResearchUK

COMPANY SPOTLIGHT

Menarini

Back to top